Information or documents not available now must be given to ASX as soon as available.
Information and documents given to ASX become ASX’s property and may be made public.
Name of Entity:
CLINUVEL PHARMACEUTICALS LTD
88 089 644 119
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
|Direct or indirect interest||Indirect Interest|
Nature of indirect interest (including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
|Beneficial interest in shares held by Ivorton Pty Ltd|
|Date of change||02-Mar-21|
|No. of securities held prior to change||1,693 Ordinary Shares|
Note: If consideration is non-cash, provide details and estimated valuation
|No. of securities held after change||2,363 Ordinary Shares|
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back
Part 2 - Change of director's interests in contracts
Detail of contract
|Nature of interest|
|Name of registered holder (if issued securities)|
|Date of change|
|No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed|
|Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation|
|Interest after change|
Part 3 - Closed Period
Were the interests in the securities or contracts detailed above traded during a closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?